KØBENHAVN, DK / ACCESSWIRE / March 13, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - 13 March 2024 - FluoGuide A/S ("FluoGuide" or the "Company") today announces that Ole Larsen (CFO) has bought shares.
Member of the Executive Management Ole Larsen has bought 529 shares in the Company at an average share price of SEK 54.364.
After the buy, Ole holds 3,000 shares in the Company.
The Company has published strong results from phase II trials demonstrating the efficacy of FG001 as well as showing it was well tolerated and safe from clinical trials in patients undergoing surgery to remove aggressive brain (high-grade glioma), head & neck and lung cancers. Based on this strong foundation, FluoGuide expands the scope of application of FG001 and advance the development toward approval in aggressive brain cancer. FluoGuide is listed on Nasdaq First North Growth Market, Stockholm under the ticker "FLUO". Read more about FluoGuide's pipeline, technology, and upcoming events on
Attachments
Chief Financial Officer (CFO) Ole Larsen buys shares
Notification to Danish FSA
SOURCE: FluoGuide A/S
View the original press release on accesswire.com